The MATCH (Medication Aids for Tobacco Cessation and Health) Study

NACompletedINTERVENTIONAL
Enrollment

968

Participants

Timeline

Start Date

May 1, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Tobacco Use DisorderNicotine Dependence
Interventions
DRUG

Bupropion

DRUG

Varenicline

BEHAVIORAL

Weekly Motivational Emails

The e-mails will include tips on several things other than the medications that participants can do to help them quit smoking. The contents of the emails will vary from week to week. The e-mails will provide tips on ways to create an atmosphere that promotes quitting and staying abstinence. They will also include recommendations on how to address issues with withdrawal symptoms and cravings. In addition, they will provide positive motivational messages by stating facts on benefits of quitting smoking.

Trial Locations (1)

M5T 1P7

Centre for Addiction and Mental Health, Nicotine Dependence Clinic, Toronto

All Listed Sponsors
collaborator

Global Research Awards for Nicotine Dependence (GRAND)

UNKNOWN

lead

Centre for Addiction and Mental Health

OTHER

NCT02146911 - The MATCH (Medication Aids for Tobacco Cessation and Health) Study | Biotech Hunter | Biotech Hunter